Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

West Pharma Services' Shares Rise 10% on Q1 Sales Growth and Raised FY Earnings Guidance

Shares of West Pharmaceutical Services traded higher and established a new 52-week high price after the firm reported Q1/20 earnings that included a 10.8% increase in YoY revenues. Global healthcare packaging components manufacturer company West Pharmaceuti...
Streetwise Reports | April 24, 2020 |

Important Economic News Calendar: October 14 – October 18, 2019

The markets basically ignored the Fed talk last week, as U.S. - China trade war developments stole investors’ attention away from the scheduled news releases. But it was worth paying attention to our last week’s News Calendar that highlighted U....
Paul Rejczak | October 15, 2019 |

Medicus Pharma advances cancer treatment towards phase II trial

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Our next company is Medicus Pharma Ltd. (TSXV:MDCX) , headquartered in Philadelphia, Pennsylvania. The company is a publicly traded clinical stage, multi-st...
Ryan Dhillon | January 22, 2024 |

Deciphera's Shares Open 115% Higher on Phase 3 Ripretinib Results

Deciphera Pharmaceuticals announced positive top-line results from the INVICTUS pivotal phase 3 clinical study of ripretinib in patients with advanced gastrointestinal stromal tumors. Early this morning, clinical-stage biopharmaceutical company Deciphera Pharmaceutic...
Streetwise Reports | August 14, 2019 |

Shares Rise as The Medicines Company Reports Positive Topline Results...

Shares Rise as The Medicines Company Reports Positive Topline Results from Two Phase 3 Cholesterol Trials The Medicines Company's shares are trading 8.5% higher today after the firm reported positive results from two phase 3 studies for inclisiran, one for familial hype...
Streetwise Reports | September 26, 2019 |

Best-in-class Cannabis = Best-in-class Investment Opportunity

(CLICK IMAGE TO PLAY VIDEO) Today, in the publicly-traded retail cannabis sector, you need to deliver not only a quality, brand-name product but consistent shareholder value. Enter the new name in the game – Chalice Brands Ltd. ( CSE.CHAL , OTCMKTS: CHALF...
Dave Jackson | July 8, 2021 |

What re-opening success or failure means for metals

“There is a Chinese curse which says ‘May he live in interesting times.’ Like it or not we live in interesting times. They are times of danger and uncertainty; but they are also more open to the creative energy of men than any other time in history.&CloseCurl...
Richard (Rick) Mills | May 22, 2020 |

Top 3 Currency Pairs Teeming with Profits

The euro bulls have repelled the bears’ attack yesterday though the bears are again making headway. Will they be able to break through today? The Philadelphia Fed Manufacturing Index surprised on the upside, lending support to the U.S. currency. Our short euro ...
Nadia Simmons | May 16, 2019 |

Gold Jumps Above $1,400 after Dovish Fed

Last week was definitely hot. Both major central banks adopted a more dovish stance. Gold reacted positively, jumping above $1,400. What has changed, and what has not? How close are we to an actual rate cut, not only to the speculation of getting one for sure on the next Fed m...
Arkadiusz Sieron | June 26, 2019 |

Lannett Signs Exclusive U.S. Distribution Deal with Sinotherapeutics; Shares Up 40%

Shares of Lannett Co. are up 40% today after announcing that it secured rights to be the exclusive U.S. distributor of Sinotherapeutics' antifungal drug that is an AB-rated generic for Noxafil. This morning generic drug maker Lannett Company Inc. (LCI:NYSE.MKT) anno...
Streetwise Reports | August 29, 2019 |
1 2 3 4 5 6 7 8 9 10 ...
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested